Comparison of hospitalizations in patients on first generation versus second generation long acting injectable (LAI) antipsychotics

被引：0
|
作者：
Rasool, Seemab [1 ]
Venan, Paster [1 ]
机构：
[1] Essex Partnership Univ NHS Fdn Trust, Wickford, England
来源：
BJPSYCH OPEN | 2021年 / 7卷
关键词：
D O I：
10.1192/bjo.2021.753
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [1] First-generation versus second-generation long-acting injectable antipsychotics in schizophrenia: cognitive impairment
    Romero Guillena, S. L.
    Plasencia Garcia de Diego, B. O.
    Sanchez-luengo, F. Gotor
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S512 - S513
  • [2] COMPARISON OF RESOURCE USE AND HEALTH CARE COSTS IN NEW INITIATORS OF LONG-ACTING INJECTABLE (LAI) AND ORAL SECOND GENERATION ANTIPSYCHOTICS
    Seetasith, A.
    Burudpakdee, C.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A464 - A464
  • [3] Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
    Jann, Michael W.
    Penzak, Scott R.
    [J]. CNS DRUGS, 2018, 32 (03) : 241 - 257
  • [4] Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
    Michael W. Jann
    Scott R. Penzak
    [J]. CNS Drugs, 2018, 32 : 241 - 257
  • [5] Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia
    Pesa, Jacqueline
    Liu, Zhiwen
    Fu, Alex Z.
    Campbell, Alicia K.
    Grucza, Richard
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 261 : 170 - 177
  • [6] Second Generation Long-Acting Injectable Antipsychotics in Africa: About a Case
    Galvan, J.
    Nguepy-Keubo, F. R.
    [J]. EUROPEAN PSYCHIATRY, 2023, 66 : S820 - S820
  • [7] Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
    Michael W. Jann
    Scott R. Penzak
    [J]. CNS Drugs, 2018, 32 : 603 - 603
  • [8] New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
    Citrome, Leslie
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (07) : 767 - 783
  • [9] Practical guidelines for the use of long-acting injectable second-generation antipsychotics
    Jarema, Marek
    Wichniak, Adam
    Dudek, Dominika
    Samochowiec, Jerzy
    Bienkowski, Przemyslaw
    Rybakowski, Janusz
    [J]. PSYCHIATRIA POLSKA, 2015, 49 (02) : 225 - 241
  • [10] Cardiovascular risk factors in outpatients receiving long acting injectable second generation antipsychotics
    Draghici, A.
    Manea, M. O.
    Andor, M.
    Tomescu, M. C.
    Dehelean, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S504 - S504
12345